| Tag | Content |
|---|
EnhancerAtlas ID | HS145-10268 |
Organism | Homo sapiens |
Tissue/cell | NHBE |
Coordinate | chr17:55434780-55435280 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr17:55434823-55434844 | ACCTCCCCTCCCTCCTGCTCT | - | 6.59 |
|
| | Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
| SE_13162 | chr17:55434128-55435509 | CD34_Primary_RO01480 | | SE_13320 | chr17:55431989-55436119 | CD34_Primary_RO01536 | | SE_14121 | chr17:55433396-55435794 | CD34_Primary_RO01549 | | SE_25325 | chr17:55429055-55436649 | DND41 | | SE_33983 | chr17:55433492-55436644 | HCC1954 | | SE_44002 | chr17:55431045-55436974 | MM1S | | SE_58585 | chr17:55412383-55457551 | Ly1 | | SE_60364 | chr17:55414130-55445745 | Ly4 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I057354 | chr17 | 55431972 | 55436207 |
|
Enhancer Sequence | AGCTGGATCC AGCCACTTGA GCTTCATTCG GCAGCACACA GACACCTCCC CTCCCTCCTG 60
CTCTGCCCCA GACCTTGTGC TTTCTTGGCA CCGCTGGGTC GTGCCTGCTC AGACCTGGTC 120
AGTGTGCTTG CCAGGGCGAG GAGAGCTTTG CATAGGCCGC TGCTGCTTAC TTATTAACGA 180
TGACGCTGGT GGGAGCTGCG CCACCAGCTC CCTATCCAGG CCTTTGTGGT TGCATCCTGT 240
TCACATAAAG GTGAAATCAT GACCTGCCCG ACTTGATTTT TCAGTTGAGG GGCTTTTGTG 300
TATGTGTCGT TCTTGATCCA GTAAGAGGAT TGTGCTTTCA TTCACAAAGA TTTGATCAGT 360
AAATAGGAAG AGAAAATACT CAAGGGAGAA ATGCTTAGTG TTCCGATTAA TACATTAATC 420
TTTTTTTTTG ATGAGCTGAA GGTGCTCTGT TGTTTCTCTT GACTGAGTCT TTGCCCTTAC 480
CTTTGACCTT AGTGACTTGA 500
|
